Tri-agonist profile: GLP-1, GIP, glucagon
Lyophilised for stability, easy reconstitution
Suitable for subcutaneous administration in approved research protocols
Manufactured to strict quality standards and supplied through a reliable fulfilment process.
What is Retatrutide?
Retatrutide is a triple-receptor agonist peptide studied for effects on body weight regulation, glycaemic control, and metabolic markers.
Key factors
Benefits of Retatrutide
Quality you can verify
Produced to research-grade standards
Lyophilised form for improved shelf stability
Stored and shipped with peptide integrity in mind
Retatrutide 10 mg Peptide (Research Grade)
$159.00
In stock
| Quantity | Discount | Price |
|---|---|---|
| 2-3 | 10% | $143.10 |
| 4 | 20% | $127.20 |
| 5-10 | 30% | $111.30 |
How Does It Work
Retatrutide:
tri-agonist peptide
Retatrutide is a tri-agonist peptide that engages GLP-1, GIP, and glucagon receptors. In research settings this pathway triad is studied for effects on appetite signals, gastric emptying, insulin dynamics, and energy expenditure.
Reviews
Trusted By More Than 10000+ Customers
Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Frequently Asked Questions
Lyophilised powder in a 10 mg vial.
No. Research use only. Not a therapeutic good. No medical advice is provided.
Reconstitute with bacteriostatic water to the desired concentration. Store refrigerated at 2–8°C. Follow your institution’s protocols.
Many research protocols use weekly subcutaneous administration with cautious titration. Geno X does not recommend dosing.
Orders ship in 24–48 business hours.
Yes. 2 vials 10% off, 3 vials 20% off, 5 vials 30% off.
Geno X supplies research-grade peptides to Australian laboratories and advanced research users. We prioritise clarity, quality, and fast fulfilment.
Geno X supplies research-grade peptides. Not for human use. Not a therapeutic good. No medical advice provided.
Copyright © 2025 GenoX. All Rights Reserved.